ACS 2010
Recent articles
Uncharted territory
Drug companies have been curiously reluctant to dive into research on therapies for autism. The chief of Pfizer's new autism research unit explains why.
Uncharted territory
Drug companies have been curiously reluctant to dive into research on therapies for autism. The chief of Pfizer's new autism research unit explains why.
True blood
Early data suggest that it is possible to identify autism by looking at gene expression in the blood. But it’s going to take more work to prove it.
True blood
Early data suggest that it is possible to identify autism by looking at gene expression in the blood. But it’s going to take more work to prove it.
Database groups common concepts in autism tests
A searchable new database will greatly ease the task of comparing results from more than 25 diagnostic tests for autism, by creating clusters of the various symptoms measured.
Database groups common concepts in autism tests
A searchable new database will greatly ease the task of comparing results from more than 25 diagnostic tests for autism, by creating clusters of the various symptoms measured.
Explore more from The Transmitter
Unconfounding genetic and environmental factors, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 31 August.
Unconfounding genetic and environmental factors, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 31 August.
Amid funding uncertainty, neuroscientists report a mix of cynicism, persistence
Two years into one of the most tumultuous tenures in U.S. federal funding, researchers outline how they are coping with ongoing changes and reflect on the impact these changes are having on the system more broadly.
Amid funding uncertainty, neuroscientists report a mix of cynicism, persistence
Two years into one of the most tumultuous tenures in U.S. federal funding, researchers outline how they are coping with ongoing changes and reflect on the impact these changes are having on the system more broadly.
Reimagining Mexico’s brain bank
Since Alzheimer’s disease researcher José Luna-Muñoz assumed leadership of the facility—Latin America’s oldest—in 2011, he has been acquiring additional tissue types and is working to expand donor recruitment to rural areas.
Reimagining Mexico’s brain bank
Since Alzheimer’s disease researcher José Luna-Muñoz assumed leadership of the facility—Latin America’s oldest—in 2011, he has been acquiring additional tissue types and is working to expand donor recruitment to rural areas.